Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 9,12 | 9,12 | 2025-06-26 |
| Valcuria Holding AB | 3,61 | 3,61 | 2025-06-26 |
| Hans Mandahl | 2,16 | 2,16 | 2025-06-26 |
| Nicholas Peebo | 1,76 | 1,76 | 2025-06-26 |
| Hartmut Wiese | 1,45 | 1,45 | 2025-06-26 |
| Göran Lennart Rehn | 1,37 | 1,37 | 2025-06-26 |
| Erik Boström | 1,14 | 1,14 | 2025-06-26 |
| Ben Hayes | 1,03 | 1,03 | 2025-06-26 |
| Hans Harvig | 0,99 | 0,99 | 2025-06-26 |
| Christian Müller | 0,98 | 0,98 | 2025-06-26 |
2025-11-11 Delårsrapport 2025-Q3
2026-02-10 Bokslutskommuniké 2025
